Trademark: 97309325
Word
TREAT AND MAINTAIN
Status
Dead
Status Code
602
Status Date
Thursday, June 15, 2023
Serial Number
97309325
Mark Type
4000
Filing Date
Saturday, March 12, 2022
Abandoned Date
Friday, June 2, 2023
Trademark Owner History
EyePoint Pharmaceuticals US, Inc.
Classifications
5 Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion and retinal disease; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion and retinal disease
10 Sustained drug delivery systems for ocular drugs
Trademark Events
Jun 15, 2023
Abandonment Notice E-Mailed - Failure To Respond
Jun 15, 2023
Abandonment Notice Mailed - Failure To Respond
Jun 15, 2023
Abandonment - Failure To Respond Or Late Response
Dec 1, 2022
Notification Of Non-Final Action E-Mailed
Dec 1, 2022
Non-Final Action E-Mailed
Dec 1, 2022
Non-Final Action Written
Dec 1, 2022
Assigned To Examiner
Mar 17, 2022
New Application Office Supplied Data Entered
Mar 16, 2022
New Application Entered
JB JELII A LA MODE BOUTIQUE LLC
ESSENCE 92
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov